The top South Korean biotech firm Macrogen a leader in gene sequencing has started developing a big data blockchain based platform in cooperation with the local tech company Bigster.
As a result of this new partnership, blockchain technology will be used to create a big data medical ecosystem that will enable the company securely and privately store and transfer big amounts of sensitive genomic and personal information.
According to their statement, the technology advancements in genomics are restructuring the world’s view towards medicine, enabling patients to be treated with individually customized diagnose for better treatment and prevention. This big data medical framework includes and integrates personal genomic, health and lifestyle information which is very sensitive and has high value for both the pharmaceutical and healthcare industries.
Yang Kap-seok, the CEO of Macrogen has stated:
“Despite its wide utility, gene data has been difficult to move around due to privacy protection issues and technological barriers. We hope that our upcoming blockchain-based platform will allow health care genetic and medical big data to be circulated freely.”
Both companies are planning to co-develop this new platform by June mid 2019 and have dedicated themselves to create a permissioned blockchain that can be programmed to restrict the access to specific institutions like the biotech companies, hospitals, research institutes and pharmaceutical firms.
A couple of months ago in May the American company Nebula Genomics together with Longenesis for the first time ever have used blockchain for a secure exchange of genomic data.